Novartis Pharma AG, Technical Research & Development (TRD), CH-4002 Basel, Switzerland.
Langmuir. 2013 Aug 13;29(32):10229-37. doi: 10.1021/la401993q. Epub 2013 Jul 31.
Thermo-sensitive gelling systems, like chitosan/polyol-phosphate, are candidates with a high potential for the design of biodegradable drug delivery systems, notably for in situ forming depots. They consist of stable and low viscosity aqueous solutions, liquid at room temperature, which turn into a gel state upon an increase of temperature (e.g., after subcutaneous administration). This technology enables a sustained release of potentially encapsulated active substances. Despite these thermo-gelling solutions being widely studied for the development of parenteral drug delivery systems, most commonly using β-glycerophosphate (β-GP) as gelling agent, the mechanism inducing the gelation and the role of the polyol part in this mechanism has not been clearly elucidated. To investigate the mechanism of the gelation process, comprehensive rheological studies were performed, comparing different chitosan/polyol-phosphate systems varying in the chemical structure of the polyol parts of the gelling agents. As reference, β-GP was compared to glucose-1-phosphate (G1-P) and glucose-6-phosphate (G6-P) and to a polyol-free phosphate salt, Na2HPO4, as well. Frequency sweep experiments at different temperatures or different gelling agent concentrations, temperature, and time sweep tests were performed as complementary experimental approaches. The results disclosed significant trends with widespread implications, establishing a relationship between the chemical structure of the polyol part and the macroscopic gelling behavior of the solutions, that is, transition temperature, gelation time, and gel strength. The new results presented in this study show that increasing the size of the polyol part prevents the interactions between the chitosan chains, strongly influencing the gelling process.
温敏凝胶系统,如壳聚糖/多元醇-磷酸盐,具有很大的潜力可用于设计可生物降解的药物传递系统,特别是原位形成的储库。它们由稳定且低粘度的水溶液组成,在室温下为液态,当温度升高时(例如,皮下给药后)变成凝胶状态。该技术能够使潜在包裹的活性物质持续释放。尽管这些温敏凝胶溶液已广泛用于开发注射用药物传递系统,最常用的是β-甘油磷酸酯(β-GP)作为凝胶剂,但诱导凝胶化的机制以及多元醇部分在该机制中的作用尚未明确阐明。为了研究凝胶化过程的机制,进行了全面的流变学研究,比较了不同的壳聚糖/多元醇-磷酸盐系统,这些系统在凝胶剂多元醇部分的化学结构上有所不同。作为参考,将β-GP 与葡萄糖-1-磷酸(G1-P)和葡萄糖-6-磷酸(G6-P)以及无多元醇的磷酸盐盐 Na2HPO4 进行了比较。在不同温度或不同凝胶剂浓度下进行频率扫描实验,以及温度和时间扫描实验作为补充实验方法。结果显示出具有广泛影响的显著趋势,在多元醇部分的化学结构和溶液的宏观凝胶行为之间建立了关系,即转变温度、凝胶化时间和凝胶强度。本研究中提出的新结果表明,增大多元醇部分的尺寸可以阻止壳聚糖链之间的相互作用,从而强烈影响凝胶化过程。